| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/13/2008 | US7371739 Aryl fructose-1,6-bisphosphatase inhibitors |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371379 Epidermal growth factors (ErbB2); gene expression inhibition; anticancer agents |
| 05/13/2008 | US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders |
| 05/13/2008 | US7371366 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 05/13/2008 | CA2469343C Combination of cytochome p450 dependent protease inhibitors |
| 05/13/2008 | CA2468449C Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/13/2008 | CA2327395C New imidazotriazolopyrimidines, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | CA2283326C An aqueous metal bicarbonate solution and method of use |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/13/2008 | CA2196995C Spiro-azabicyclic compounds useful in therapy |
| 05/13/2008 | CA2184916C Use of fibroblast growth factors to stimulate bone growth |
| 05/13/2008 | CA1341573C Recombinant gamma interferons having enhanced stability and methods therefor |
| 05/08/2008 | WO2008054756A2 Sesquiterpene lactones from artemisia leucodes as anti-inflammatory and gene regulators |
| 05/08/2008 | WO2008054540A2 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| 05/08/2008 | WO2008053920A1 Physiologically active substance-containing granular composition and method of producing the same |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053812A1 Cyanopyridine derivative and medicinal use thereof |
| 05/08/2008 | WO2008053728A1 Agent for promoting healing of living body |
| 05/08/2008 | WO2008053517A1 Agent for promoting in vivo dha synthesis and seaweed oil |
| 05/08/2008 | WO2008052671A2 Combination therapy of substituted oxazolidinones |
| 05/08/2008 | WO2007149797A3 Use of organic compounds |
| 05/08/2008 | WO2005030211A8 Aerosol formulation for inhalation, containing an anticholinergic agent |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108796 Human IL-1 epsilon DNA and polypeptides |
| 05/08/2008 | US20080108713 identifying an individual who has an altered risk for developing psoriasis; medcal diagnosis and analysis; detecting a SNP haplotype; drug screening; treatment with biodrugs |
| 05/08/2008 | US20080108711 Use of the Slug Gene or the Replication, Transcription or Expression Products Thereof in the Identification, Diagnosis, Prevention or Treatment of the Spread of Cancer and/or the Development of Metastasis |
| 05/08/2008 | US20080108701 Diagnostic Agent for Tumor |
| 05/08/2008 | US20080108696 Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases |
| 05/08/2008 | US20080108689 Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists |
| 05/08/2008 | US20080108671 Non-systemic control of parasites |
| 05/08/2008 | US20080108670 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 05/08/2008 | US20080108653 Tripeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108650 Such as 3-isobutyryl-2-isopropyl pyrazolo[1,5-a]pyridine; for treatment of Parkinson's disease, Huntington's disease, Alzheimer's disease, and schizophrenia |
| 05/08/2008 | US20080108648 Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/08/2008 | US20080108631 Human protein tyrosine phosphatase inhibitors an methods of use |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108617 Modulators of pharmacokinetic properties of therapeutics |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108596 Antiserotonine agents; psycholgical disorders; headaches; kits |
| 05/08/2008 | US20080108588 NO-alendronate; NO-pamidronate; NO-clodronate; NO-risedronate; NO-zolendronate; NO-etidronate; NO-ibandronate; NO-tiludronate; NO-neridronate; NO-olpadronate; NO-icadronate; NO-YH529; additional agent such as growth hormones, bone morphogenic proteins enhances bone growth or decreases bone resorption |
| 05/08/2008 | US20080108581 consist of DNA sequence-specific ligand capable of recognizing sequence common to genes of pathological interest ( as IGF-1, IGF-1R, VEGF, BCL2), linker arm, and topoisomerase I posion (as camptothecins, rebeccamycins, minor groove ligands, benzimidazoles); dismetabolic, autoimmune diseases, HIV and HCV |
| 05/08/2008 | US20080108576 Novel cytostatic conjugates with integrin ligands |
| 05/08/2008 | US20080108572 measuring the level of relaxin expression in a pregnant woman, comparing measured level of relaxin to a level of relaxin associated with normal placental development , a lower measured level of relaxin correlates with an increased risk of developing a condition associated with placental insufficiency |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080108560 Heterologous G-Csf Fusion Proteins |
| 05/08/2008 | US20080108547 Protease Inhibitor |
| 05/08/2008 | US20080108134 Extracellular matrix tisuse comprised of cultured fibroblast for use in grafting to patient with tissue or organ defect; safety testing for pharmaceutical, cosmetic and chemical products |
| 05/08/2008 | US20080107792 Use of Plants with Increased Levels of Flavonol Glycosides in Reducing Hypertension |
| 05/08/2008 | US20080107754 Dietary supplement and a method to enhance sleep and lucid dreaming |
| 05/08/2008 | US20080107753 Compositions to alleviate menopausal symptoms |
| 05/08/2008 | US20080107750 Graft materials containing ecm components, and methods for their manufacture |
| 05/08/2008 | US20080107741 Angiogenesis inhibitor particles having a particle size of less than 2000 nm; and associated with the surface thereof at least one surface stabilizer |
| 05/08/2008 | US20080107737 Crosslinked Amine Polymers |
| 05/08/2008 | US20080107728 Formula and method for making relief lozenges and method by which ingredients in lozenges are delivered to user |
| 05/08/2008 | US20080107726 Compositions comprising beta-adrenergic receptor antagonists and diuretics |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107710 Matrix material of a membrane sheet from native insoluble collagen I, or collagen III; matrix material carrying a nucleic acid sequence encoding a protein that promotes cell growth |
| 05/08/2008 | US20080107705 Administering locally for disc disorders |
| 05/08/2008 | US20080107686 Such as granulocyte-macrophage colony stimulating factor; cytokines; kits; capsules |
| 05/08/2008 | US20080107683 Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof |
| 05/08/2008 | US20080107680 Linked to polyoxyethylene glycol via oximination |
| 05/08/2008 | US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107674 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/08/2008 | US20080107673 Clostridial polypeptide for use in prevention and treatment of microorganismal infcetion |
| 05/08/2008 | US20080107667 Fusion peptide for use in targeting cells for lympocytic destruction; immunotherapy |
| 05/08/2008 | US20080107666 Non-Glycosylated Recombinant Collagen-Like Polypeptides |
| 05/08/2008 | US20080107663 Tri1 Cells for Use in Atherosclerosis |
| 05/08/2008 | US20080107661 Using cell free system for identifying agents which prevent mucin and chronic myelogenous leukemia ligand binding; antitumor agents; treating cell proliferative, nervous system, inflammatory and atherosclerotic disorders |
| 05/08/2008 | US20080107660 Binding Agents |
| 05/08/2008 | US20080107652 Using transgenic, probiotic microorgansims as therapeutic vechicles for prevention and treatment of infection in shrimp |
| 05/08/2008 | US20080107649 Virosomes as adjuvants; cyclization; screening antibodies |
| 05/08/2008 | US20080107648 Immunoglobulin specific to delta-like ligand 4 (DII4) for use in prevention and treatment of cell proliferative disorders |
| 05/08/2008 | US20080107647 Methods and Compositions Relating to Ccr5 Antagonist, Inf-Y and Il-13 Induced Inflammation |
| 05/08/2008 | US20080107642 Antibodies against gpr64 and uses thereof |
| 05/08/2008 | US20080107639 Secreted glycoprotein for use in prevention and treatment of obesity, diabetes, osteoarthritis, liver and hypertensive disorders |
| 05/08/2008 | US20080107637 Using inhalabe gas comprising ethyl nitrite as means of nitrosylating hemoglobin, delaying tumor growth and preventing destruuctive tissue damage associated with inflammation |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107626 Adjuvant agent for hepatitis C |
| 05/08/2008 | US20080107605 From a clone comprising complete nucleotide sequence for the expression of the TSH |
| 05/08/2008 | US20080107604 Method for the Prediction of the Risk Potential for Cancerous Diseases and Inflammatory Intestinal Diseases and Corresponding Tests |
| 05/08/2008 | US20080107596 Breast cancer specific genes; a polynucleotide, a protein expressed by a polynucleotide, a polynucleotide capable of hybridizing under stringent conditions |
| 05/08/2008 | US20080107595 Anti-CCR5 antibody |
| 05/08/2008 | DE202008003004U1 Lutschpastille Lozenge |
| 05/08/2008 | CA2667826A1 Inhibitors of histone deacetylase |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918716A2 Screening for agents modulating TGF-Beta cell signalling |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |